In Vivo Imaging of the Tumor-Associated Enzyme NCEH1 with a Covalent PET Probe
Overview
Authors
Affiliations
Herein, we report the development of an F-labeled, activity-based small-molecule probe targeting the cancer-associated serine hydrolase NCEH1. We undertook a focused medicinal chemistry campaign to simultaneously preserve potent and specific NCEH1 labeling in live cells and animals, while permitting facile F radionuclide incorporation required for PET imaging. The resulting molecule, [ F]JW199, labels active NCEH1 in live cells at nanomolar concentrations and greater than 1000-fold selectivity relative to other serine hydrolases. [ F]JW199 displays rapid, NCEH1-dependent accumulation in mouse tissues. Finally, we demonstrate that [ F]JW199 labels aggressive cancer tumor cells in vivo, which uncovered localized NCEH1 activity at the leading edge of triple-negative breast cancer tumors, suggesting roles for NCEH1 in tumor aggressiveness and metastasis.
Cai M, Luo J, Yang C, Yang X, Zhang C, Ma L iScience. 2023; 26(12):108340.
PMID: 38053637 PMC: 10694648. DOI: 10.1016/j.isci.2023.108340.
Spatial Chemoproteomics for Mapping the Active Proteome.
Swenson C, Smitha Pillai K, Carlos A, Moellering R Isr J Chem. 2023; 63(3-4).
PMID: 38046285 PMC: 10688764. DOI: 10.1002/ijch.202200104.
Covalent Proteins as Targeted Radionuclide Therapies Enhance Antitumor Effects.
Klauser P, Chopra S, Cao L, Bobba K, Yu B, Seo Y ACS Cent Sci. 2023; 9(6):1241-1251.
PMID: 37396859 PMC: 10311652. DOI: 10.1021/acscentsci.3c00288.
KIAA1363-A Multifunctional Enzyme in Xenobiotic Detoxification and Lipid Ester Hydrolysis.
Wagner C, Hois V, Taschler U, Schupp M, Lass A Metabolites. 2022; 12(6).
PMID: 35736449 PMC: 9229287. DOI: 10.3390/metabo12060516.
Chemical Probes and Activity-Based Protein Profiling for Cancer Research.
Mazid M, Park S, Rao Cheekatla S, Murale D, Shin K, Lee J Int J Mol Sci. 2022; 23(11).
PMID: 35682614 PMC: 9180054. DOI: 10.3390/ijms23115936.